Jiangsu Recbio Technology Co., Ltd.

SEHK:2179 Stock Report

Market Cap: HK$3.9b

Jiangsu Recbio Technology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:2179 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Nov 24SellHK$378,000Shenzhen Fuhai Xinwan Equity Investment Fund Management Enterprise (L.P.)Company45,000HK$8.40

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2179?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders15,384,7803.21%
Private Companies38,082,3407.95%
Institutions73,539,60515.3%
Employee Share Scheme85,913,62017.9%
VC/PE Firms103,564,60021.6%
General Public162,667,05533.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 18 shareholders own 66.05% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.3%
Taizhou Yuangong Technology Partnership (Limited Partnership)
82,863,620HK$682.0m0%no data
8.74%
Lhasa Junqi Enterprise Management Co., Ltd.
41,861,020HK$344.5m0%no data
7.8%
Shanghai Chaorui Medical Technology Partnership (Limited Partnership)
37,390,030HK$307.7m0%no data
7.2%
Lyfe Capital
34,499,840HK$283.9m0%39.74%
5.68%
Shenzhen Qianhai Woying Investment Management Co., Ltd
27,203,740HK$223.9m0%no data
4.78%
Jiangsu Zhaoyin Industry Fund Management Co., Ltd.
22,907,700HK$188.5m0%no data
3.29%
Shenzhen Fuhai Xinwan Equity Investment Fund Management Enterprise (L.P.)
15,770,630HK$129.8m-1.1%no data
2.5%
Temasek Holdings (Private) Limited
12,000,000HK$98.8m0%0.01%
2.3%
Liu Yong
11,027,820HK$90.8m0%no data
1.87%
Sequoia Capital Operations LLC
8,962,500HK$73.8m0%0.05%
1.46%
Shenzhen Oriental Fortune Venture Capital Management Co., Ltd.
6,986,120HK$57.5m0%34.57%
1.24%
Legend Capital Management Co., Ltd.
5,921,380HK$48.7m0%0.45%
0.64%
Hongyan Liu
3,075,500HK$25.3m0%no data
0.32%
Taizhou Baibei Biology Technology Partnership (Limited Partnership)
1,525,000HK$12.6m0%no data
0.32%
Taizhou Guquan Biology Technology Partnership (Limited Partnership)
1,525,000HK$12.6m0%no data
0.27%
Jiayi Zhao
1,281,460HK$10.5m0%no data
0.21%
Shenzhen Oriental Fortune Capital Co., Ltd.
991,275HK$8.2m0%0.34%
0.14%
Shenzhen Fuhai Preffered No. 2 High-Tech Venture Capital Partnership (Limited Partnership)
692,310HK$5.7m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 07:35
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jiangsu Recbio Technology Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCMB International Securities Limited
Sean WuMorgan Stanley
Youjue HuMorgan Stanley